View all IQVIA events


Explore how groundbreaking cell and gene therapies (CAGTs) are revolutionizing previously untreatable diseases to improve the quality of life for patients. Join experts from IQVIA Biotech and IQVIA as they address the current state of CAGTs, regulatory strategies that move innovation forward and critical clinical development decisions.
Erin Finot, MS, MBA
Vice President, Immuno-Oncology and CAGT
Diego Correa, MD, PhD, MSc
Vice President and Global Head, Cell and Gene Therapy Center of Excellence
Patrick Brady, PharmD
Global Head, Therapeutic Innovation and Regulatory Science